Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Peter Higgins
🇨🇦
Canada
Country
🇨🇦
Canada
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)
Phase 3
Withdrawn
Conditions
Crohn's Disease
Interventions
Drug: Placebo
Drug: Adalimumab PRN
Drug: Adalimumab
Subscribe
First Posted Date
2012-08-28
Last Posted Date
2017-05-24
Lead Sponsor
Peter Higgins
Registration Number
NCT01674413
Locations
🇺🇸
University of Michigan Health System, Ann Arbor, Michigan, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy